Warning For Facebook “Likes” Reflects FDA Social Media Approach
This article was originally published in The Pink Sheet Daily
FDA is revealing its views on social media use through individual enforcement actions and provisions in disparate guidances, in the absence of issuing an overarching guidance. A recent warning letter sheds light on the agency’s view of “liking” something on Facebook.
You may also be interested in...
Regular under-reporting of serious adverse event reports has spurred FDA to have its good manufacturing practice inspectors review dietary supplement firms’ AERs and reporting practices, FDA’s Fabricant says. Key compliance issues can tip off the agency that a company may be falling short on reporting.
The Federal Trade Commission soon will issue updated guidance about how endorsers and marketers should disclose financial relationships on blogs, Twitter and other social media platforms. The original guidance issued in 2000 was published before social networking boomed.
FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.